Application of Information Technology: Evaluation of an Online Platform for Cancer Patient Self-reporting of Chemotherapy Toxicities

The current mechanism for monitoring toxicity symptoms in cancer trials depends on a complex paper-based process. Electronic collection of patient-reported outcomes (PROs) may be more efficient and accurate. An online PRO platform was created including a simple data entry interface, real-time report generation, and an alert system to e-mail clinicians when patients self-report serious toxicities. Feasibility assessment involving 180 chemotherapy patients demonstrated high levels of use at up to 40 follow-up clinic visits per patient over 16 months (85% of patients at any given visit), with high levels of patient and clinician acceptance and satisfaction (>95%). Alerts were used as the basis for delayed chemotherapy treatments, dose modifications, and scheduling changes. These results demonstrate that online patient-reporting is a feasible strategy for chemotherapy toxicity symptom monitoring, and may improve safety and satisfaction with care. Ongoing multi-center research will evaluate the impact of this approach on clinical and administrative outcomes.

[1]  J. V. Von Roenn,et al.  An item bank was created to improve the measurement of cancer-related fatigue. , 2005, Journal of clinical epidemiology.

[2]  E. Basch,et al.  Use of information resources by patients with cancer and their companions , 2004, Cancer.

[3]  J. V. Von Roenn,et al.  An item response theory-based pain item bank can enhance measurement precision. , 2005, Journal of pain and symptom management.

[4]  J F Fries,et al.  The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. , 2005, Clinical and experimental rheumatology.

[5]  M. Barry,et al.  Patient-re ported complications and follow-up treatment after radical prostatectomy , 1993 .

[6]  R. Willke,et al.  Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. , 2004, Controlled clinical trials.

[7]  D. Gustafson,et al.  An Evidence-Based Approach to Interactive Health Communication: A Challenge to Medicine in the Information Age , 1998 .

[8]  A. Gnanasakthy,et al.  Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[9]  Ramesh Farzanfar,et al.  Telephone-linked care for cancer symptom monitoring: a pilot study. , 2002, Cancer practice.

[10]  D. Sargent,et al.  Early detection of toxicity and adjustment of ongoing clinical trials: the history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  R. Hays,et al.  Clinical significance of patient-reported questionnaire data: another step toward consensus. , 2005, Journal of clinical epidemiology.

[12]  高橋 聡,et al.  Common Terminology Criteria for Adverse Events (CTCAE) v3.0による胃癌術後合併症の解析 , 2006 .

[13]  David Cella,et al.  The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation , 2003, Health and quality of life outcomes.

[14]  Joseph Finkelstein,et al.  Testing the Usability of Two Automated Home-Based Patient-Management Systems , 2004, Journal of Medical Systems.

[15]  I S Kohane,et al.  Using a pen-based computer to collect health-related quality of life and utilities information. , 1995, Proceedings. Symposium on Computer Applications in Medical Care.

[16]  D. Sargent,et al.  Rapid reporting and review of an increased incidence of a known adverse event. , 2000, Journal of the National Cancer Institute.

[17]  Nandita Mitra,et al.  Patient online self-reporting of toxicity symptoms during chemotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  C. Gwede,et al.  Assessment of toxicity in cooperative oncology clinical trials: the long and short of it. , 2002, The Journal of oncology management : the official journal of the American College of Oncology Administrators.

[19]  M. Malin,et al.  The revolution in radiation therapy. , 2002, The Journal of oncology management : the official journal of the American College of Oncology Administrators.

[20]  T N Robinson,et al.  An evidence-based approach to interactive health communication: a challenge to medicine in the information age. Science Panel on Interactive Communication and Health. , 1998, JAMA.

[21]  M. Barry,et al.  Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993). , 1993, Urology.

[22]  L. Morris,et al.  The regulation of patient-reported outcome claims: need for a flexible standard. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[23]  D. Fairclough,et al.  Patient reported outcomes as endpoints in medical research , 2004, Statistical methods in medical research.

[24]  M. Kris,et al.  Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. , 2006, The Lancet. Oncology.

[25]  Charles Safran,et al.  A Web-based Rapid Prototyping and Clinical Conversational System that Complements Electronic Patient Record System , 2001, MedInfo.

[26]  Galina Velikova,et al.  Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Ingela Wiklund,et al.  Assessment of patient‐reported outcomes in clinical trials: the example of health‐related quality of life , 2004, Fundamental & clinical pharmacology.

[28]  N. Leidy,et al.  Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[29]  David H. Gustafson,et al.  Wired for health and well-being : the emergence of interactive health communication , 1999 .

[30]  David Cella,et al.  Measuring the side effects of taxane therapy in oncology , 2003, Cancer.